Peripheral administration of IL-6 interrupts insulin signaling due to enhance expression of SOCS3 in hepatocytes suggesting that obesity-induced IL-6 expression mediates insulin resistance (Senn et al., 2003). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.